Malaysia: Public consultations on allied health professions and stem cell guidelines

In brief

The Ministry of Health Malaysia (MOH) is carrying out two public consultations on: (1) governance framework for the unregulated allied health professions in Malaysia; and (2) new edition of guidelines on stem cell and cell-based research and therapy.

The deadlines to respond to the public consultations are 30 September 2023 and 4 October 2023 respectively.   


In more detail

Allied health professions

Coming into operation on 1 July 2020, the Allied Health Professions Act 2016 (AHPA) currently regulates 16 professions, namely audiologist, dietitian, entomologist (public health), physiotherapist, medical physicist, nutritionist, clinical psychologist, diagnostic radiographer, medical laboratory scientist, occupational therapist, speech-language therapist, radiation therapist, medical laboratory technologist, dental technologist, environmental health officer and health education officer.

MOH has now identified the following 6 areas of allied health professions as unregulated, whether under AHPA or other legislation in Malaysia:

  • Cardiovascular technology
  • Perfusion
  • Sonography
  • Music therapy
  • Genetic counselling
  • Prosthetics and orthotics

("Identified Professions")

The current public consultation seeks to explore the different options of governance framework for the Identified Professions, namely status quo, self-regulation, co-regulation, explicit government regulation or non-regulatory.

Click here for the consultation document and to respond to the public consultation by 30 September 2023.

Stem cell guidelines

MOH is seeking feedback and comments on the draft Guidelines on Stem Cell and Cell-Based Research and Therapy.

This draft is slated to be the third edition of the guidelines, which will replace the current edition published more than 10 years ago in July 2009, known as the Guidelines for Stem Cell Research and Therapy.

The new edition of the draft guidelines provides a lot more guidance than the current edition. The following areas are addressed specifically in more detail:

  • Stem cell types and research recommendations
  • Cell and tissue therapies for non-homologous use
  • Pre-clinical or non-clinical testing recommendations for advanced therapeutics
  • Current legislation and guidelines of cell and gene therapy products (CGTPs) in Malaysia 
  • Checklist for research on stem cell and cell-based therapies

Click here to respond to the public consultation by 4 October 2023.

* * * * *

LOGO Malaysia_Wong & Partners_KualaLumpur

This client alert was issued by Wong & Partners, a member firm of Baker McKenzie International, a global law firm with member law firms around the world. In accordance with the common terminology used in professional service organizations, reference to a "partner" means a person who is a partner or equivalent in such a law firm. Similarly, reference to an "office" means an office of any such law firm. This may qualify as "Attorney Advertising" requiring notice in some jurisdictions. Prior results do not guarantee a similar outcome.

Contact Information

Copyright © 2024 Baker & McKenzie. All rights reserved. Ownership: This documentation and content (Content) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms). The Content is protected under international copyright conventions. Use of this Content does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All Content is for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulations and practice are subject to change. The Content is not offered as legal or professional advice for any specific matter. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any Content. Baker McKenzie and the editors and the contributing authors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The Content may contain links to external websites and external websites may link to the Content. Baker McKenzie is not responsible for the content or operation of any such external sites and disclaims all liability, howsoever occurring, in respect of the content or operation of any such external websites. Attorney Advertising: This Content may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Content may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. Reproduction: Reproduction of reasonable portions of the Content is permitted provided that (i) such reproductions are made available free of charge and for non-commercial purposes, (ii) such reproductions are properly attributed to Baker McKenzie, (iii) the portion of the Content being reproduced is not altered or made available in a manner that modifies the Content or presents the Content being reproduced in a false light and (iv) notice is made to the disclaimers included on the Content. The permission to re-copy does not allow for incorporation of any substantial portion of the Content in any work or publication, whether in hard copy, electronic or any other form or for commercial purposes.